Intercept Pharmaceuticals, Inc. (ICPT)

  • 2021-10-15 16:00:03
  • NasdaqGS
  • Nasdaq Real Time Price
  • USD
16.82 -0.96 (-5.40%)
52 Week Range
11.6 - 40.41
Key Stats
Open 17.90
Day High 17.90
Day Low 16.82
Previous Close 17.78
52 Week High 40.41
52 Week Low 11.60
50 Day Average 15.40
200 Day Average 17.77
Market Cap 482.4M
Shares Out 28.7M
Book Value -6.12
EPS -5.14
P/E -
P/B -2.75
Earnings Date 2021-07-29
Technical Indicators (Daily)
RSI(14) 58.38
STOCH(14) 63.04
AROON(25) 24.00
SD(21) 2.37
MA(50) 15.14
EMA(50) 15.82
MACD(12,26) 0.46

Intercept Pharmaceuticals, Inc. is an American biopharmaceutical company incorporated in 2002, focusing on the development of novel synthetic bile acid analogs to treat chronic liver diseases, such as primary biliary cirrhosis now called primary biliary cholangitis, non-alcoholic fatty liver disease, cirrhosis, portal hypertension, primary sclerosing cholangitis and also the intestinal disorder, bile acid diarrhea.

Latest News
5 Stocks With 195% to 467% Upside, According to Wall Street
Wed, 08 Sep 2021 10:06:00 +0000

If the high-water price target for each of the following five stocks were to come to fruition, shareholders would be looking at gains ranging from a low of 195% to as much as 467%. If you're "only" l...

Latest Comments

Related Stocks

Disclaimer: The data contained in Super Surge website is not necessarily real-time nor accurate and may differ from the actual market data. Prices, volumes, ratios, charts and indicators are indicative and not appropriate for trading purposes. Super Surge doesn't bear any responsibility for any trading losses you might incur as a result of using this data.